Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2581 AL 2595

Designed Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly

Kalmouni M, Oh Y, Alata W, Magzoub M.

Pharmaceutics. 2024 Nov 12;16(11):1443. doi: 10.3390/pharmaceutics16111443.

Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician's Perspective

Sturchio A, Rocha EM, Kauffman MA, Marsili L, Mahajan A, Saraf AA, Vizcarra JA, Guo Z, Espay AJ.

Brain Sci. 2024 Jan 31;14(2):151. doi: 10.3390/brainsci14020151.

Unraveling neuroprotection in Parkinson's disease: Nrf2-Keap1 pathway's vital role amidst pathogenic pathways

Kaur T, Sidana P, Kaur N, Choubey V, Kaasik A.

Inflammopharmacology. 2024 Oct;32(5):2801-2820. doi: 10.1007/s10787-024-01549-1. Epub 2024 Aug 13.

Pathological pain: Non-motor manifestations in Parkinson disease and its treatment

Lei J, Tang LL, You HJ.

Neurosci Biobehav Rev. 2024 Jun;161:105646. doi: 10.1016/j.neubiorev.2024.105646. Epub 2024 Apr 1.

Physical exercise-mediated neuroprotective mechanisms in Parkinson's disease, Alzheimer's disease, and epilepsy

Pinho RA, Muller AP, Marqueze LF, Radak Z, Arida RM.

Braz J Med Biol Res. 2024 Nov 25;57:e14094. doi: 10.1590/1414-431X2024e14094. eCollection 2024.

The Radboud dysarthria assessment: validity and reliability of the Arabic version

Summaka M, Nasser Z, Hannoun S, Daoud R, Zein H, Al-Thalaya Z, Hamadeh ZA, Koubaisy N, Jebahi F, Naim I, Harati H.

Disabil Rehabil. 2024 Oct;46(21):5104-5113. doi: 10.1080/09638288.2023.2297809. Epub 2023 Dec 27.

Parkinson's Disease Bradykinesia, Forward Posture, and Drug-Induced Pisa Syndrome Alleviated With Traditional Japanese Acupuncture: A Case Report

Masuda T, Egawa K, Takeshita Y, Tanaka K.

Cureus. 2024 Oct 4;16(10):e70860. doi: 10.7759/cureus.70860. eCollection 2024 Oct.

Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromine

Zarrilli B, Giacomet C, Cossa F, Federici M, Berretta N, Mercuri NB.

Parkinsonism Relat Disord. 2024 Nov;128:107158. doi: 10.1016/j.parkreldis.2024.107158. Epub 2024 Sep 21.

Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions

O'Shea DM, Arkhipenko A, Galasko D, Goldman JG, Sheikh ZH, Petrides G, Toledo JB, Galvin JE.

Front Neurol. 2024 Apr 22;15:1395413. doi: 10.3389/fneur.2024.1395413. eCollection 2024.

The association between alterations in motor and cognitive dimensions of schizophrenia-spectrum disorders: A systematic review

Moura BM, Madeira L, Bakker PR, van Harten P, Marcelis M.

Schizophr Res. 2024 May;267:398-414. doi: 10.1016/j.schres.2024.04.014. Epub 2024 Apr 18.

Cardiac arrest during deep brain stimulation: A case report

Oberholzer J, Fayolle D, Vandenbulcke A, Gaudet JG.

Clin Case Rep. 2024 Jul 11;12(7):e9147. doi: 10.1002/ccr3.9147. eCollection 2024 Jul.

Coexistence of Parkinson's disease and myasthenia gravis: A case report and literature review

Mao Z, Nie Q, Xue Z, Li Z.

Exp Ther Med. 2024 May 13;28(1):282. doi: 10.3892/etm.2024.12570. eCollection 2024 Jul.

[Vowel articulation and intelligibility of speech in Spanish speakers with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus]

Castillo-Triana N, Camargo-Mendoza M.

Rev Neurol. 2024 Sep 29;79(5):121-127. doi: 10.33588/rn.7905.2024108.

Buty and the beast: the complex role of butyrate in Parkinson's disease

Elford JD, Becht N, Garssen J, Kraneveld AD, Perez-Pardo P.

Front Pharmacol. 2024 Apr 17;15:1388401. doi: 10.3389/fphar.2024.1388401. eCollection 2024.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias